NA
ABEO icon

NewEdge Advisors’s Abeona Therapeutics ABEO Stock Holding History

NewEdge Advisors’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Hold
1
– – ﹤0.01% 4174
2026
Q1 		$2 Hold
1
– – ﹤0.01% 4119
2025
Q4 		$2 Sell
1
-225
-100% -$1.13K ﹤0.01% 4198
2025
Q3 		$1.19K Buy
226
+225
+22,500% +$1.43K ﹤0.01% 3858
2025
Q2 		$6 Hold
1
– – ﹤0.01% 3972
2025
Q1 		$5 Hold
1
– – ﹤0.01% 3918
2024
Q4 		$6 Hold
1
– – ﹤0.01% 3871
2024
Q3 		$6 Buy
+1
New +$5 ﹤0.01% 3789

Other funds holding ABEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NewEdge Advisors's ABEO Position: Q2 2026 in Review

NewEdge Advisors held its Abeona Therapeutics (ABEO) position steady in Q2 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #4174.

NewEdge Advisors first reported a position in ABEO in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.19K in Q3 2025. 80 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • NewEdge Advisors held 1 share of Abeona Therapeutics worth $4 as of Q2 2026.
  • NewEdge Advisors left its Abeona Therapeutics share count unchanged in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #4174 holding.
  • NewEdge Advisors first reported a position in Abeona Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • NewEdge Advisors's Abeona Therapeutics position peaked at $1.19K in Q3 2025.
  • 80 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.